Search

everythinglearnresearchcommunity

for

Search:↓

Telogen effluvium is a common hair loss condition where many hairs enter the resting phase, often not noticeable until significant loss occurs, and treatment focuses on the underlying cause.

Hair growth and shedding are linked and can be disrupted, causing a delay known as the hair eclipse phenomenon, which is common in certain hair conditions and could lead to new treatments.

Telogen Effluvium causes more hair loss because hair moves to the resting phase too soon.

Hair loss from Telogen Effluvium usually gets better within 6 months after addressing the cause.

Pregnancy causes skin changes like darkening, hair thickening, nail changes, and increased risk of skin growths, most of which usually resolve after birth.

The document concludes that Telogen Effluvium is a hair loss disorder that can be assessed with the modified wash test and may be treated with clobetasol foam, with patient management being important.

Etretinate therapy can cause hair loss by disrupting the hair growth cycle.

The study concluded that a special imaging technique showed women with hair loss have slower hair growth and a faulty hair replacement cycle.

Vemurafenib therapy can cause hair loss, but clobetasol propionate foam can help regrow hair.

Aging scalp skin contributes to hair aging and loss, and more research is needed to develop better hair loss treatments.

Telogen Effluvium is a condition causing excessive hair loss due to stress, illness, drugs, or hormonal changes, and can be treated with specific products or naturally resolves after 3-4 years.

Lithium therapy may cause temporary hair loss, with possible regrowth if treatment is stopped or continued.

Oral contraceptives may cause hair loss in women.

Only about 20% of women have hair loss after childbirth severe enough to be considered clinically significant.

A woman had temporary hair loss after a facelift, which improved on its own within a year.

COVID-19 and related stress may increase hair loss known as Telogen effluvium.

Gasdermin A3 causes hair follicle stem cells to activate too early, leading to hair loss.

Telogen Effluvium is a common hair loss condition, particularly in women, with no specific FDA-approved treatment, and recovery can take up to 18 months.

Minoxidil can increase hair density, speed up regrowth in transplanted hair, and slow down further hair loss, especially beneficial for women, young men with thinning hair, and those wanting to reconstruct the back of the scalp.

Telogen effluvium is a type of hair loss where more hair than normal falls out after stress or illness.

Certain long non-coding RNAs are important for controlling hair growth cycles in sheep.

Telogen effluvium is a form of hair loss caused by various factors and requires identifying the cause for proper treatment.

Taking Kera-Diet® improves hair and nail health without side effects.

Telogen Effluvium is a condition where more hair than usual falls out after stress or fever.

Stress hormone CRF causes hair loss and stops hair cell growth.

A woman's temporary hair loss was caused by high prolactin levels from her medication.

Pregnancy can cause more body and scalp hair growth and make nails brittle, but these changes often revert after giving birth.

A woman had temporary hair loss due to a stress-related condition after a facelift.

The poem ends by asking for case reports on serious health issues like Telogen Effluvium.

Hypothyroidism patients with hair loss typically have thinning hair, smaller hair follicles, and normal hair shedding.